KR20010070901A - manufacturing method for chondroitin sulfate and its content - Google Patents
manufacturing method for chondroitin sulfate and its content Download PDFInfo
- Publication number
- KR20010070901A KR20010070901A KR1020010034425A KR20010034425A KR20010070901A KR 20010070901 A KR20010070901 A KR 20010070901A KR 1020010034425 A KR1020010034425 A KR 1020010034425A KR 20010034425 A KR20010034425 A KR 20010034425A KR 20010070901 A KR20010070901 A KR 20010070901A
- Authority
- KR
- South Korea
- Prior art keywords
- chondroitin sulfate
- extract
- cartilage
- exchange resin
- ethanol
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0003—General processes for their isolation or fractionation, e.g. purification or extraction from biomass
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0069—Chondroitin-4-sulfate, i.e. chondroitin sulfate A; Dermatan sulfate, i.e. chondroitin sulfate B or beta-heparin; Chondroitin-6-sulfate, i.e. chondroitin sulfate C; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Materials Engineering (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Sustainable Development (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
본 발명은 콘드로이친 황산 및 그 함유물의 제조방법에 관한 것으로, 더욱 상세하게는, 동물의 결합조직의 주성분인 콘드로이친 황산을 소연골로부터 추출하여 고순도로 정제함과 동시에 그 함유물을 제조하는 콘드로이친황산 및 그 함유물 제조방법에 관한것이다.The present invention relates to a chondroitin sulfate and a method for producing the same, and more particularly, chondroitin sulfate to extract the chondroitin sulfuric acid, the main component of the animal connective tissue from the small cartilage to purify the high purity and to produce the contents at the same time and It relates to a method for producing the contents.
현재 의학의 발달로 인간의 평균수명이 연장되었으나, 이와 더불어 골다공증, 류마티스, 관절염, 변형성 관절염 등의 퇴행성 질환으로 고통받고 있는 환자들 또한 증가하고 있는 실정이다.The current life expectancy of humans has been extended, but in addition, patients suffering from degenerative diseases such as osteoporosis, rheumatism, arthritis and deformable arthritis are also increasing.
콘드로이친황산은 고령화에 의한 퇴행성질환, 뇌세포괴사 및 안구건조의 예방, 완화 및 치료효과가 탁월한 것으로 알려지고 있다.Chondroitin sulfate is known to be effective in preventing, relieving and treating degenerative diseases caused by aging, brain cell necrosis and dry eye.
종래에는 상기의 콘드로이친황산을 상어연골이나 달팽이를 원료로 하여 50mM아세트산나트륨 완충용액에 0.15M 염화칼륨 또는 4.0M 구아니디니움 클로라이드(guanidinium chloride)용액으로 추출한 다음, 원심분리하고 염을 제거하기 위하여 장시간 투석한 후, 동결건조하는 방법으로 제조되었으나, 추출방법이 복잡하고 염을 제거하기 위한 투석장치 등의 설비가 필요하며, 대량생산에 제약을 받게되며 고순도의 정제가 어렵다는 문제점이 있었다.Conventionally, the chondroitin sulfate is extracted from 0.15M potassium chloride or 4.0M guanidinium chloride solution in 50mM sodium acetate buffer, using shark cartilage or snail as a raw material, and then centrifuged to remove salt. After dialysis, it was prepared by the method of freeze-drying, but the extraction method is complicated, and a facility such as a dialysis apparatus for removing salts is required, and there is a problem that it is difficult to purify the high purity and high purity.
그리고 상기와 같이 제조된 콘드로이친황산도 거의 전량수입에 의존한다는 문제점 또한 있다.In addition, chondroitin sulfate prepared as described above also has a problem in that almost all depend on imports.
따라서, 본 발명은 상기한 문제점을 해결하기 위해 안출된 것으로, 소연골에서 콘드로이친황산을 추출하고 고순도의 콘드로이친황산으로 정제시킴과 동시에 그 함유물을 제조하여 의약품, 화장품용원료, 일반식품용원료, 건강식품 및 건강보조식품등의 원료로 사용가능한 콘드로이친황산 및 그 함유물 제조방법을 제공하는 것을 목적으로 한다.Accordingly, the present invention has been made to solve the above problems, extract chondroitin sulfate from bovine cartilage and purify with high purity chondroitin sulfate, and at the same time to produce the contents of pharmaceuticals, cosmetic raw materials, general food raw materials, An object of the present invention is to provide a method for producing chondroitin sulfate and its contents which can be used as raw materials for health foods and health supplements.
도1 - 본 발명에 따른 콘드로이친황산 및 그 함유물 제조공정을 나타낸 공정도.1 is a process diagram showing a process for producing chondroitin sulfate and its contents according to the present invention.
상기한 목적을 달성하기 위한 본 발명은, 소연골을 희석 염산용액에 침지하여 불순물을 제거시키는 불순물 제거과정과; 상기 불순물 제거과정을 거친 소연골을 가압용기에 투입하여 가압상태에서 가열시키는 가압가열과정과; 단백질 분해효소를 첨가하여 연골로부터 콘드로이친황산 성분이 포함된 추출액을 추출시키는 추출과정과; 추출액의 pH를 조정하여 콘드로이친황산이외의 단백질을 제거시키는 단백질 제거과정과; 추출액을 이온교환수지를 이용하여 이온성염류와 아민을 제거시키는 정제과정과; 그리고, 알콜을 이용하여 콘드로이친황산 및 그 염을 분리하는 분리과정;을 포함하여 구성되는 콘드로이친황산 및 그 함유물 제조방법을 기술적 요지로 한다.The present invention for achieving the above object, the impurity removal process to remove impurities by dipping small cartilage in dilute hydrochloric acid solution; A pressurized heating process of putting the small cartilage that has undergone the impurity removal process into a pressurized container and heating it under a pressurized state; An extraction process of adding a protease to extract an extract containing chondroitin sulfate component from cartilage; Adjusting the pH of the extract to remove proteins other than chondroitin sulfate; Purifying the extract using ion exchange resin to remove ionic salts and amines; In addition, a separation process for separating chondroitin sulfuric acid and its salts using an alcohol; and a method for producing chondroitin sulfate and its contents comprising a technical gist.
여기서, 상기 불순물 제거과정을 거친 소연골은 에탄올로 세척되는 것이 바람직하다.Here, the small cartilage that has undergone the impurities removal process is preferably washed with ethanol.
그리고, 상기 정제과정후에 가성소다 용액으로 추출액의 pH가 중화되는 것이 바람직 하다.Then, the pH of the extract is neutralized with caustic soda solution after the purification process.
그리고, 상기 정제과정에 사용되는 이온교환수지는 양이온 교환수지와 음이온 교환수지가 혼합되고, 상기 분리과정에 사용되는 알콜은 에탄올, 메탄올, 프로필알콜, 부필알콜로 구성되는 그룹 중 적어도 하나 이상을 포함여 구성되는 것이 바람직하다.In addition, the ion exchange resin used in the purification process is a cation exchange resin and an anion exchange resin is mixed, the alcohol used in the separation process includes at least one or more of the group consisting of ethanol, methanol, propyl alcohol, butyl alcohol. Is preferably configured.
이에 따라, 소연골에서 콘드로이친황산을 추출하고 고순도의 콘드로이친황산으로 정제시킴과 동시에 그 함유물을 제조하여 의약품, 화장품용원료, 일반식품용원료, 건강식품 및 건강보조식품등의 원료로 사용가능한 콘드로이친황산 및 그 함유물 제조된다는 이점이 있다.Therefore, chondroitin sulfate can be extracted from bovine cartilage, refined into high purity chondroitin sulfate, and the contents thereof can be prepared to be used as raw materials for medicines, cosmetic raw materials, general food raw materials, health foods and health supplements. There is an advantage in that sulfuric acid and its contents are prepared.
이하 첨부된 도면을 참조로 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail with reference to the accompanying drawings.
도1은 본 발명에 따른 콘드로이친황산 및 그 함유물 제조공정을 나타낸 공정도이다.1 is a process chart showing a process for producing chondroitin sulfate and its contents according to the present invention.
도시된 바와 같이, 본 발명에 따른 콘드로이친황산 및 그 함유물 제조방법은 크게 불순물 제거과정과, 가압가열과정과, 추출과정과, 단백질 제거과정과, 정제과정과, pH중화과정 그리고 분리과정으로 구성된다.As shown, chondroitin sulfate and a method for producing the same according to the present invention is largely composed of an impurity removal process, pressurized heating process, extraction process, protein removal process, purification process, pH neutralization process and separation process do.
먼저 불순물 제거과정에 대해 설명한다.First, the impurity removal process will be described.
상기 불순물 제거과정은 소연골에 포함된 혈액 및 기타 불순물을 제거하는 과정으로, 소연골을 pH 1.0∼6.0 정도되는 희석 염산용액에 침지시켜 소연골에 포함된 혈액 및 회분류들을 제거시킨다. 이때 침지시간은 3시간 ∼ 30시간이 적당하며 생산성 향상을 위해서는 짧을수록 좋지만, 시간이 너무 짧으면 회분의 제거율이 감소된다.The impurity removal process is a process of removing blood and other impurities contained in the small cartilage, and the small cartilage is immersed in dilute hydrochloric acid solution having a pH of about 1.0 to 6.0 to remove the blood and ash contained in the small cartilage. At this time, the immersion time is suitable for 3 to 30 hours, the shorter the better for the productivity improvement, but if the time is too short, the removal rate of the ash is reduced.
표1은 희석염산용액의 침지시간과 회분함량과의 관계를 나타낸 표이다.Table 1 shows the relationship between the dipping time of dilute hydrochloric acid solution and ash content.
표1에 나타난 바와 같이, 침지시간이 길어질수록 잔류회분의 함량은 줄어듦을 알 수 있으며, 상기의 점을 고려하여 볼 때, 가장 적당한 시간은 18시간 정도가 바람직하다.As shown in Table 1, as the immersion time increases, the content of residual ash decreases. In view of the above point, the most suitable time is preferably about 18 hours.
상기 희석 염산용액에의 침지에 의한 불순물 제거과정을 거친 소연골은 95%의 알콜로 세척되어 기타 불순물이 제거된다.The small cartilage, which has undergone the impurity removal process by dipping in dilute hydrochloric acid solution, is washed with 95% alcohol to remove other impurities.
알콜로 세척된 소연골은 다음단계의 원료로 사용된다.Bovine cartilage washed with alcohol is used as a raw material for the next step.
알콜세척과정을 거친 소연골은 가압가열과정이 진행되는 바, 소연골에서 콜라겐과 강한 결합을 하고 있는 콘드로이친 황산을 추출하기 위한 과정이다.The alcoholic cartilage bovine cartilage is a process for extracting chondroitin sulfate which is strongly bound to collagen from the barium cartilage.
가압가열과정은 소연골을 가압솥에 투입한 후, 100℃∼130℃로 가열하여 추출물을 추출시킨다.In the pressure heating process, the cartilage is put into a pressure cooker, and then heated to 100 ° C to 130 ° C to extract the extract.
가압시간은 1시간 ∼ 6시간 정도에서 이루어진다.Pressurization time is made in about 1 hour-about 6 hours.
표2는 가압가열추출시간과 콘드로이친황산의 수율을 나타낸표이다.Table 2 shows the pressurized heating extraction time and the yield of chondroitin sulfate.
표2에 나타난 바와 같이, 가압시간이 증가함에 따라 수율이 증가하는 것으로 나타났다. 그러나 제조경비와 생산성을 고려해 볼 때 3시간 정도 가압가열하는 것이 바람직하다.As shown in Table 2, the yield increased with increasing pressurization time. However, considering the production cost and productivity, it is preferable to heat the pressure for about 3 hours.
다음은 상기 가압가열과정에서 추출된 추출물을 이용하여 콜라겐 등과 같은 단백질과 결합하고 있는 콘드로이친황산을 재차 분리하기 위한 추출과정이 진행된다.Next, an extraction process for re-isolating chondroitin sulfate, which binds to a protein such as collagen, is performed using the extract extracted in the pressurization heating process.
상기의 추출과정은 상기 가압가열과정에서 추출된 추출물에 알카라제, 뉴트라제, 펩신, 파파인 등을 포함하는 단백질 분해효소를 0.1% ∼ 0.5% 정도 투입하여 가수분해시킴에 의해 콘드로이친황산을 분리해 낸다.In the extraction process, chondroitin sulfate is separated by hydrolysis by adding 0.1% to 0.5% of a protease including alcarase, neutrase, pepsin, papain, etc. to the extract extracted in the pressurized heating process. Serve
표3은 가수분해시간과 콘드로이친황산의 수율을 나타낸표이다.Table 3 shows the hydrolysis time and the yield of chondroitin sulfate.
표3에 나타난 바와 같이, 가수분해시간이 증가하면 콘드로이친황산의 수율도 증가함을 알 수 있다. 그리고 12시간 이상 추출할 경우, 수율은 일정부분 증가하나, 분해시 추출물의 변성이 일어나게 되어 최종 산물로서의 가치가 상실되었다.As shown in Table 3, it can be seen that as the hydrolysis time increases, the yield of chondroitin sulfate also increases. In case of extracting for more than 12 hours, the yield increased to a certain degree, but the decomposition resulted in denaturation of the extract, which lost its value as a final product.
따라서, 생산성등을 고려해 보건데 수율의 증가폭이 최대인 4시간정도를 가수분해하는 것이 가장 적당한 것으로 나타났다.Therefore, in consideration of productivity, it was found that it is most suitable to hydrolyze about 4 hours when the increase in yield is the maximum.
상기 추출과정을 거친 추출물에는 여전히 콜라겐, 미분해 단백질 등의 잔류불순물들이 존재하는 바, 잔류 불순물을 제거하기 위해 다음 과정으로 단백질 제거과정이 진행된다.Residues such as collagen and undecomposed protein are still present in the extract that has undergone the extraction process. In order to remove residual impurities, a protein removal process proceeds to the next process.
상기 단백질 제거과정은 상기 추출과정에서 추출된 추출물에 수산화나트륨용액을 투입함에 의해 진행되며, pH를 7.5∼9.0으로 조정하여 침전시킨 후에 여과시킴에 의해 불순물을 제거시킨다.The protein removal process is carried out by adding a sodium hydroxide solution to the extract extracted in the extraction process, by adjusting the pH to 7.5 ~ 9.0 to precipitate and remove impurities by filtration.
상기 단백질 제거과정을 거친 추출물은 정제과정이 진행되는 바, 정제과정은 이온교환수지를 이용하여 추출물에 포함된 염류와 아민을 제거시키는 과정이다.The extraction process of the protein removal process is a purification process, the purification process is a process of removing the salts and amines contained in the extract by using an ion exchange resin.
즉, 상기 추출물에는 콘드로이친황산 외에도 많은 염들과 담백질 분해물들이 아민형태로 존재하므로, 고순도의 콘드로이친황산을 정제하기 위하여 양이온교환수지를 이용하여 양이온성 염류와 아민을 흡착시키고, 음이온교환수지를 이용하여 음이온성 염류를 흡착시켜 제거시킨다.That is, in the extract, many salts and protein decomposition products exist in the form of amines in addition to chondroitin sulfate, so that cationic salts and amines are adsorbed using a cation exchange resin to purify chondroitin sulfate of high purity, and anion is used by using an anion exchange resin. The salts are adsorbed and removed.
정제과정에 사용되는 이온교환수지는 스티렌 및 디비닐벤젠의 공중합체로 이루어진 다공성고분자 물질의 일반적인 시판용 수지들을 이용하였다. 그리고 이온교환수지의 활성화는 양이온교환수지의 경우에는 염산용액으로 통과시킨 후 정제수로 수세하고, 음이온교환수지는 수산화나트륨용액으로 통과시킨 후 정제수로 수세하여 사용하였다.Ion-exchange resins used in the purification process used commercially available resins of porous polymer materials composed of copolymers of styrene and divinylbenzene. In the case of cation exchange resin, the activation of the ion exchange resin was passed through hydrochloric acid solution and washed with purified water, and the anion exchange resin was passed through sodium hydroxide solution and washed with purified water.
활성화된 이온교환수지는 양이온 교환수지와 음이온 교환수지를 혼합하여 사용하였다.The activated ion exchange resin was used by mixing a cation exchange resin and an anion exchange resin.
표4는 양이온교환수지와 음이온교환수지의 부피비와 콘드로이친황산의 수율을 나타낸 표이다.Table 4 is a table showing the volume ratio of the cation exchange resin and anion exchange resin and the yield of chondroitin sulfate.
표4에 나타난 바와 같이, 양이온교환수지:음이온교환수지의 부피비가 9:1이 될때 콘드로이친황산의 수율이 가장 우수한 것으로 나타났다.As shown in Table 4, the yield of chondroitin sulfate was the best when the volume ratio of cation exchange resin: anion exchange resin was 9: 1.
상기의 정제과정을 거치게 되면 추출액에는 고순도의 콘드로이친황산이 존재하는 바, 물에 대한 용해성을 증가시키기 위해 pH 중화과정이 진행된다.After the above purification process, high purity chondroitin sulfate is present in the extract, and a pH neutralization process is performed to increase solubility in water.
상기의 pH 중화과정은 추출물을 가성소다용액으로 중화시킴에 의해 진행되며, 상기의 과정을 거치게 되면 추출물의 물에 대한 용해성이 증가되어 의약품용,화장품용원료, 일반식품용원료, 건강식품 및 건강보조식품의 원료로 사용하기에 적당한 상태가 된다.The pH neutralization process is carried out by neutralizing the extract with a caustic soda solution, and after the above process, the solubility of the extract is increased to increase the solubility of water in pharmaceuticals, cosmetic raw materials, general food raw materials, health food and health It is in a state suitable for use as a raw material for supplements.
다음으로는 콘드로이친황산을 분리시키는 분리과정이 진행된다.Next, a separation process for separating chondroitin sulfate is performed.
분리과정은 중화된 추출액을 에탄올을 사용하여 콘드로이친 황산을 침전시키고, 침전된 콘드로이친 황산을 회수하여 다시 에탄올을 사용하여 세척시킨 후 건조시켜 콘드로이친황산을 얻는다.In the separation process, the neutralized extract is precipitated with chondroitin sulfate using ethanol, the precipitated chondroitin sulfate is recovered, washed with ethanol and dried to obtain chondroitin sulfate.
상기의 분리과정에서는 에탄올을 사용하였지만 에탄올에 한정되지 아니하고 메탄올, 프로필알콜, 부틸알콜 및 그 이성체 중 1종 또는 2종 이상의 혼합물을 사용하여도 된다.Although ethanol is used in the separation process, one or a mixture of two or more of methanol, propyl alcohol, butyl alcohol, and isomers thereof may be used.
다음은 고순도의 콘드로이친황산을 추출하는 구체적인 실시예에 대해 설명한다.The following describes a specific example of extracting high purity chondroitin sulfate.
< 실시예1 ><Example 1>
희석염산용액을 이용하여 불순물 처리과정을 거친 소연골 500g을 정제수 5000ml를 가하여 121℃에서 3시간 가압가열추출한 후, 추출액을 pH 6.5, 온도 50℃로 조절하여 알카라제를 0.3% 정도 가하고 4시간정도 가수분해 하였다. 이를 pH 8.5로 조정하고 약 1시간 후에 침전이 형성된 것을 확인하고, 규조토를 이용하여 여과시켰다. 여과액을 양이온교환수지와 음이온교환수지가 9:1로 혼합되어 충전된 수지탑에 분당 50ml의 유속으로 용출시켜 용출액을 가성소다로 중화시켰다.500 g of bovine cartilage, which was subjected to impurity treatment using dilute hydrochloric acid solution, was added to 5000 ml of purified water, and then extracted by pressurized heating at 121 ° C. for 3 hours. Hydrolysis to a degree. It was adjusted to pH 8.5, and after about 1 hour, it was confirmed that a precipitate was formed and filtered using diatomaceous earth. The filtrate was mixed with a cation exchange resin and an anion exchange resin at 9: 1 and eluted at a flow rate of 50 ml per minute in a packed resin column to neutralize the eluate with caustic soda.
에탄올을 사용하여 침전된 콘드로이친황산을 회수하고 다시 에탄올로 세척시킨 후 건조시켜 13g 정도의 백색 콘드로이친 황산을 추출하였다.The precipitated chondroitin sulfate was recovered using ethanol, washed with ethanol, and dried to extract about 13 g of white chondroitin sulfate.
< 실시예2 ><Example 2>
에탄올 대신 메탄올을 이용한것을 제외하고는 실시예1과 동일한 과정을 거쳐 13g 정도의 백색 콘드로이친황산을 추출하였다.Except for using methanol instead of ethanol through the same process as in Example 1 was extracted white chondroitin sulfate of about 13g.
< 실시예3 ><Example 3>
에탄올 대신 프로필알콜을 이용한것을 제외하고는 실시예1과 동일한 과정을 거쳐 13g 정도의 백색 콘드로이친황산을 추출하였다.Except for using propyl alcohol instead of ethanol through the same process as in Example 1 was extracted white chondroitin sulfate of about 13g.
< 실시예4 ><Example 4>
에탄올 대신 부틸알콜을 이용한것을 제외하고는 실시예1과 동일한 과정을 거쳐 13g 정도의 백색 콘드로이친황산을 추출하였다.Except that butyl alcohol was used instead of ethanol, 13 g of white chondroitin sulfate was extracted through the same process as in Example 1.
< 실시예5 ><Example 5>
단백질 분해효소를 알카라제 대신에 뉴트라제를 이용한 것을 제외하고는 실시예1과 동일한 과정을 거쳐 13.5g 정도의 백색 콘드로이친황산을 추출하였다.The proteolytic enzyme was extracted with about 13.5 g of white chondroitin sulfate through the same process as in Example 1 except that nutrase was used instead of alkalase.
< 실시예6 ><Example 6>
에탄올 대신 메탄올을 이용한것을 제외하고는 실시예5와 동일한 과정을 거쳐13.5g 정도의 백색 콘드로이친황산을 추출하였다.Except for using methanol instead of ethanol through the same process as in Example 5 was extracted white chondroitin sulfate of about 13.5g.
< 실시예7 ><Example 7>
에탄올 대신 프로필알콜을 이용한것을 제외하고는 실시예5와 동일한 과정을 거쳐 13.5g 정도의 백색 콘드로이친황산을 추출하였다.Except that propyl alcohol was used instead of ethanol, white chondroitin sulfate of about 13.5 g was extracted through the same process as in Example 5.
< 실시예8 ><Example 8>
에탄올 대신 부틸알콜을 이용한것을 제외하고는 실시예5와 동일한 과정을 거쳐 13.5g 정도의 백색 콘드로이친황산을 추출하였다.Except that butyl alcohol was used instead of ethanol, white chondroitin sulfate of about 13.5 g was extracted through the same process as in Example 5.
< 실시예9 ><Example 9>
희석염산용액을 이용하여 불순물 처리과정을 거친 소연골 500g을 정제수 5000ml를 가하여 121℃에서 3시간 가압가열추출한 후, 추출액을 pH 3.0, 온도 50℃로 조절하여 펩신을 0.3% 정도 가하고 4시간정도 가수분해 하였다. 이를 pH 8.5로 조정하고 약 1시간 후에 침전이 형성된 것을 확인하고, 규조토를 이용하여 여과시켰다. 여과액을 양이온교환수지와 음이온교환수지가 9:1로 혼합되어 충전된 수지탑에 분당 50ml의 유속으로 용출시켜 용출액을 가성소다로 중화시켰다.500 g of bovine cartilage, which was subjected to impurity treatment using dilute hydrochloric acid solution, was added to 5000 ml of purified water, and extracted by pressurized heating at 121 ° C. for 3 hours. Then, the extract was adjusted to pH 3.0 and temperature of 50 ° C., and 0.3% of pepsin was added. Disassembled. It was adjusted to pH 8.5, and after about 1 hour, it was confirmed that a precipitate was formed and filtered using diatomaceous earth. The filtrate was mixed with a cation exchange resin and an anion exchange resin at 9: 1 and eluted at a flow rate of 50 ml per minute in a packed resin column to neutralize the eluate with caustic soda.
에탄올을 사용하여 침전된 콘드로이친황산을 회수하고 다시 에탄올로 세척시킨 후 건조시켜 13.2g 정도의 백색 콘드로이친 황산을 추출하였다.The precipitated chondroitin sulfate was recovered using ethanol, washed with ethanol, and dried to extract about 13.2 g of white chondroitin sulfate.
< 실시예10 ><Example 10>
에탄올 대신 메탄올을 이용한것을 제외하고는 실시예9와 동일한 과정을 거쳐 13.2g 정도의 백색 콘드로이친황산을 추출하였다.13.2 g of white chondroitin sulfate was extracted by the same process as Example 9 except that methanol was used instead of ethanol.
< 실시예11 ><Example 11>
에탄올 대신 프로필알콜을 이용한것을 제외하고는 실시예9와 동일한 과정을 거쳐 13.2g 정도의 백색 콘드로이친황산을 추출하였다.Except for using propyl alcohol instead of ethanol through the same procedure as in Example 9 was extracted white chondroitin sulfate of about 13.2g.
< 실시예12 ><Example 12>
에탄올 대신 부틸알콜을 이용한것을 제외하고는 실시예9와 동일한 과정을 거쳐 13.2g 정도의 백색 콘드로이친황산을 추출하였다.Except for using butyl alcohol instead of ethanol through the same process as in Example 9 was extracted about 13.2g of white chondroitin sulfate.
< 실시예13 ><Example 13>
희석염산용액을 이용하여 불순물 처리과정을 거친 소연골 500g을 정제수 5000ml를 가하여 121℃에서 3시간 가압가열추출한 후, 추출액을 pH 7.0, 온도 50℃로 조절하여 트립신을 0.3% 정도 가하고 4시간 정도 가수분해 하였다. 이를 pH 8.5로 조정하고 약 1시간 후에 침전이 형성된 것을 확인하고, 규조토를 이용하여 여과시켰다. 여과액을 양이온교환수지와 음이온교환수지가 9:1로 혼합되어 충전된 수지탑에 분당 50ml의 유속으로 용출시켜 용출액을 가성소다로 중화시켰다.500 g of bovine cartilage, which was subjected to impurity treatment using dilute hydrochloric acid solution, was added to 5000 ml of purified water, and extracted by pressurized heating at 121 ° C. for 3 hours. Then, the extract was adjusted to pH 7.0 and temperature of 50 ° C. and 0.3% of trypsin was added. Disassembled. It was adjusted to pH 8.5, and after about 1 hour, it was confirmed that a precipitate was formed and filtered using diatomaceous earth. The filtrate was mixed with a cation exchange resin and an anion exchange resin at 9: 1 and eluted at a flow rate of 50 ml per minute in a packed resin column to neutralize the eluate with caustic soda.
에탄올을 사용하여 침전된 콘드로이친황산을 회수하고 다시 에탄올로 세척시킨 후 건조시켜 14g 정도의 백색 콘드로이친 황산을 추출하였다.The precipitated chondroitin sulfate was recovered using ethanol, washed with ethanol, and dried to extract about 14 g of white chondroitin sulfate.
< 실시예14 ><Example 14>
에탄올 대신 메탄올을 이용한것을 제외하고는 실시예13과 동일한 과정을 거쳐 14g 정도의 백색 콘드로이친황산을 추출하였다.About 14 g of white chondroitin sulfate was extracted through the same process as in Example 13 except that methanol was used instead of ethanol.
< 실시예15 ><Example 15>
에탄올 대신 프로필알콜을 이용한것을 제외하고는 실시예13과 동일한 과정을 거쳐 14g 정도의 백색 콘드로이친황산을 추출하였다.Except for using propyl alcohol instead of ethanol through the same process as in Example 13 was extracted about 14g of white chondroitin sulfate.
< 실시예16 ><Example 16>
에탄올 대신 부틸알콜을 이용한것을 제외하고는 실시예13과 동일한 과정을 거쳐 14g 정도의 백색 콘드로이친황산을 추출하였다.Except for using butyl alcohol instead of ethanol through the same process as in Example 13 was extracted about 14g of white chondroitin sulfate.
< 실시예17 ><Example 17>
희석염산용액을 이용하여 불순물 처리과정을 거친 소연골 500g을 정제수 5000ml를 가하여 121℃에서 3시간 가압가열추출한 후, 추출액을 pH 7.0, 온도 50℃로 조절하여 파파인을 0.3% 정도 가하고 4시간 정도 가수분해 하였다. 이를 pH 8.5로 조정하고 약 1시간 후에 침전이 형성된 것을 확인하고, 규조토를 이용하여 여과시켰다. 여과액을 양이온교환수지와 음이온교환수지가 9:1로 혼합되어 충전된수지탑에 분당 50ml의 유속으로 용출시켜 용출액을 가성소다로 중화시켰다.500 g of bovine cartilage, which was subjected to impurity treatment using dilute hydrochloric acid solution, was added to 5000 ml of purified water, and then extracted by pressurized heating at 121 ° C. for 3 hours. Disassembled. It was adjusted to pH 8.5, and after about 1 hour, it was confirmed that a precipitate was formed and filtered using diatomaceous earth. The filtrate was mixed with a cation exchange resin and an anion exchange resin at 9: 1 and eluted in a packed resin column at a flow rate of 50 ml per minute to neutralize the eluate with caustic soda.
에탄올을 사용하여 침전된 콘드로이친황산을 회수하고 다시 에탄올로 세척시킨 후 건조시켜 13.5g 정도의 백색 콘드로이친 황산을 추출하였다.The precipitated chondroitin sulfate was recovered using ethanol, washed with ethanol, and dried to extract about 13.5 g of white chondroitin sulfate.
< 실시예18 ><Example 18>
에탄올 대신 메탄올을 이용한것을 제외하고는 실시예17과 동일한 과정을 거쳐 13.5g 정도의 백색 콘드로이친황산을 추출하였다.Except for using methanol instead of ethanol through the same process as in Example 17 was extracted white chondroitin sulfate of about 13.5g.
< 실시예19 ><Example 19>
에탄올 대신 프로필알콜을 이용한것을 제외하고는 실시예17과 동일한 과정을 거쳐 13.5g 정도의 백색 콘드로이친황산을 추출하였다.Except for using propyl alcohol instead of ethanol through the same procedure as in Example 17 was extracted white chondroitin sulfate of about 13.5g.
< 실시예20 ><Example 20>
에탄올 대신 부틸알콜을 이용한것을 제외하고는 실시예17과 동일한 과정을 거쳐 13.5g 정도의 백색 콘드로이친황산을 추출하였다.Except that butyl alcohol was used instead of ethanol, white chondroitin sulfate of about 13.5 g was extracted through the same process as in Example 17.
상기의 구성에 의한 본 발명은 소연골에서 콘드로이친황산을 추출하고 고순도의 콘드로이친황산으로 정제시킴에 의해 원료수급이 가능하고 대량생산이 가능하다는 효과가 있다.The present invention by the above configuration has the effect of supplying raw materials and mass production is possible by extracting chondroitin sulfate from bovine cartilage and purifying with high purity chondroitin sulfate.
그리고 고순도의 콘드로이친황산이 제조됨에 의해 의약품, 화장품용원료, 일반식품용원료, 건강식품 및 건강보조식품등의 원료로 사용가능하다는 효과가 또한 있다.In addition, since high-purity chondroitin sulfate is manufactured, it can also be used as a raw material for medicines, cosmetic raw materials, general food raw materials, health foods and health supplements.
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020010034425A KR20010070901A (en) | 2001-06-18 | 2001-06-18 | manufacturing method for chondroitin sulfate and its content |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020010034425A KR20010070901A (en) | 2001-06-18 | 2001-06-18 | manufacturing method for chondroitin sulfate and its content |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20010070901A true KR20010070901A (en) | 2001-07-27 |
Family
ID=19710992
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020010034425A KR20010070901A (en) | 2001-06-18 | 2001-06-18 | manufacturing method for chondroitin sulfate and its content |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20010070901A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100733081B1 (en) * | 2005-12-14 | 2007-06-27 | 한국푸디팜 주식회사 | Manufacturing Method for Chondroitin Sulfate from Feet of Fowl |
CN114921511A (en) * | 2022-06-29 | 2022-08-19 | 晶昌明科技贸易(上海)有限公司 | Preparation method of fish cartilage hydrolysate rich in small-molecule chondroitin sulfate |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59141511A (en) * | 1983-02-03 | 1984-08-14 | Tokyo Sankei Kagaku:Kk | Mucopolysaccharide additive |
KR960010011A (en) * | 1994-09-16 | 1996-04-20 | 김정재 | Substances and methods of inhibiting cancer growth from shark cartilage |
JP2000273102A (en) * | 1999-03-19 | 2000-10-03 | Hokkaido | Method for isolation and purification of chondroitin sulfate |
KR20020078053A (en) * | 2001-04-04 | 2002-10-18 | 주식회사 송호식품개발 | Process for purifying chondroitin sulfate |
-
2001
- 2001-06-18 KR KR1020010034425A patent/KR20010070901A/en not_active Application Discontinuation
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59141511A (en) * | 1983-02-03 | 1984-08-14 | Tokyo Sankei Kagaku:Kk | Mucopolysaccharide additive |
KR960010011A (en) * | 1994-09-16 | 1996-04-20 | 김정재 | Substances and methods of inhibiting cancer growth from shark cartilage |
JP2000273102A (en) * | 1999-03-19 | 2000-10-03 | Hokkaido | Method for isolation and purification of chondroitin sulfate |
KR20020078053A (en) * | 2001-04-04 | 2002-10-18 | 주식회사 송호식품개발 | Process for purifying chondroitin sulfate |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100733081B1 (en) * | 2005-12-14 | 2007-06-27 | 한국푸디팜 주식회사 | Manufacturing Method for Chondroitin Sulfate from Feet of Fowl |
CN114921511A (en) * | 2022-06-29 | 2022-08-19 | 晶昌明科技贸易(上海)有限公司 | Preparation method of fish cartilage hydrolysate rich in small-molecule chondroitin sulfate |
CN114921511B (en) * | 2022-06-29 | 2023-12-22 | 晶昌明科技贸易(上海)有限公司 | Preparation method of fish cartilage hydrolysate rich in small molecular chondroitin sulfate |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2509436B2 (en) | Non-phosphorylated peptide | |
WO2002066667A1 (en) | Glucosamine and method of making glucosamine from microbial biomass | |
JP3278629B2 (en) | Method for separating and purifying chondroitin sulfate | |
EP0249483B1 (en) | Method of producing substantially pure albumin | |
US11702447B2 (en) | Methods for producing collagen | |
EP4240838A1 (en) | Method of obtaining hyaluronidase from bovine testes | |
CA2349980A1 (en) | Method of producing fractions containing a high concentration of milk basic cystatin and decomposition products thereof | |
CN1129451C (en) | Process for preparing injection liquid of brain protein hydrolyzate | |
WO2004039994A1 (en) | Sodium chondroitin sulfate, chondroitin sulfate-containing material and processes for producing the same | |
KR20010070901A (en) | manufacturing method for chondroitin sulfate and its content | |
CN100542603C (en) | A kind of preparation method of sarcosine peptide glycoside injection liquid | |
CN115746170A (en) | Sodium hyaluronate purification method | |
CN112029015A (en) | Production and purification process of high-purity low-molecular-weight heparin sodium | |
US1602958A (en) | Flavoring compound and method of making same | |
RU2049472C1 (en) | Method of preparing brain tissue hydrolyzate "cerebrolyzate" | |
RU2745443C1 (en) | Method for obtaining agent with antihypoxic, regenerative activity | |
RU2049471C1 (en) | Method of preparing brain tissue hydrolyzate "cerebrolyzate" | |
TWI617315B (en) | Bass extract with an effect on the stimulation and maintenance of bone | |
KR19980041691A (en) | Method for producing chondroitin sulfate and its sodium salt from shark bone or cartilage | |
SU442800A1 (en) | The method of obtaining the drug for parenteral protein nutrition | |
JP2004189825A (en) | Method for producing sodium chondroitin sulfate | |
KR102669196B1 (en) | Method for extracting and purifying fish-derived polydeoxyribonucleotides or polynucleotides | |
JPH10191940A (en) | Improvement of quality of mozuku extract and mozuku extract | |
JP2999232B2 (en) | Method for producing protein hydrolyzate | |
CN1048629C (en) | Brain hormone production method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |